RENE.LS - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 55/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)

0.25x

Defensive

Volatility (5Y p.a.)

16.3% p.a.

5-Year Horizon

Max Drawdown (5Y)

-29.5%

5-Year Horizon

Sharpe Ratio

0.26

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+15.7%
3 Years	17.0%	-14.1%	0.65	+13.5%
5 Years	16.3%	-29.5%	0.26	+6.7%
10 Years	16.4%	-30.6%	0.1	+4.1%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).